FEMY vs. POCI, KRMD, SRTS, BLUA, BWAY, ALUR, PDEX, NVNO, STIM, and MGRM
Should you be buying Femasys stock or one of its competitors? The main competitors of Femasys include Precision Optics (POCI), KORU Medical Systems (KRMD), Sensus Healthcare (SRTS), BlueRiver Acquisition (BLUA), BrainsWay (BWAY), Allurion Technologies (ALUR), Pro-Dex (PDEX), enVVeno Medical (NVNO), Neuronetics (STIM), and Monogram Orthopaedics (MGRM). These companies are all part of the "medical" sector.
Femasys (NASDAQ:FEMY) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, community ranking, risk, profitability, analyst recommendations, dividends, media sentiment and valuation.
Femasys received 22 more outperform votes than Precision Optics when rated by MarketBeat users. Likewise, 64.71% of users gave Femasys an outperform vote while only 0.00% of users gave Precision Optics an outperform vote.
Femasys has a beta of -2.76, indicating that its share price is 376% less volatile than the S&P 500. Comparatively, Precision Optics has a beta of 0.1, indicating that its share price is 90% less volatile than the S&P 500.
In the previous week, Femasys had 1 more articles in the media than Precision Optics. MarketBeat recorded 4 mentions for Femasys and 3 mentions for Precision Optics. Femasys' average media sentiment score of 1.58 equaled Precision Optics'average media sentiment score.
Femasys presently has a consensus price target of $11.67, suggesting a potential upside of 864.19%. Given Femasys' higher possible upside, equities analysts plainly believe Femasys is more favorable than Precision Optics.
Precision Optics has higher revenue and earnings than Femasys. Precision Optics is trading at a lower price-to-earnings ratio than Femasys, indicating that it is currently the more affordable of the two stocks.
65.3% of Femasys shares are owned by institutional investors. Comparatively, 13.7% of Precision Optics shares are owned by institutional investors. 16.4% of Femasys shares are owned by insiders. Comparatively, 16.3% of Precision Optics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Precision Optics has a net margin of -8.43% compared to Femasys' net margin of -1,420.59%. Precision Optics' return on equity of -19.07% beat Femasys' return on equity.
Summary
Femasys beats Precision Optics on 9 of the 16 factors compared between the two stocks.
Get Femasys News Delivered to You Automatically
Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FEMY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
